Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne - Webster, G F; Leyden, J J; Gross, J A (J Drugs Dermatol, 2014)